Lisata Therapeuti…
USUSDLisata Therapeutics Inc. (LSE:0HS8) — Biotechnology: Pharmaceutical Preparations. Antal børser, hvor selskabets aktier handles: 2. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.
Om virksomheden
- Websted
- caladrius.com
- Sektor
- Health Care · Biotechnology: Pharmaceutical Preparations
- Hovedkontor
- New York City, United States
- Ansatte
- 21
- Grundlagt
- 2006
- Udestående aktier
- 9.01 mio. pr. 2026-08-06
- Free float
- 6.65 mio.
- Markedsværdi
- 15.56 mio. USD
- Insidere
- 22.26%
- Institutionelle investorer
- 13.41%
- Branche (SIC)
- Pharmaceutical Preparations
- ISIN
- US1280583022
- LEI
- 5493002287F62M3EGQ04
Beskrivelse
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens. Lisata Therapeutics, Inc. was formerly known as Caladrius Biosciences, Inc. and changed its name to Lisata Therapeutics, Inc. in September 2022. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
Udbytte
Ingen udbyttebetalinger fundet (tjekket 07.10.2026). Virksomheden udbetaler sandsynligvis ikke udbytte.
Nyheder denne uge
Endnu ingen nyheder fra virksomhedens websted.
Største ejere
| Ejer | Andel | Aktier | Rapportdato |
|---|---|---|---|
| Deeter Investments Llp | 4.04% | 364 479 | 2026-03-31 |
| MAZZO DAVID J (Officer a… | ≈3.46% | 311 890 | 2026-01-09 |
| Vanguard Capital Managem… | 3.09% | 278 837 | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.12% | 191 371 | 2026-06-30 |
| Yakira Capital Managemen… | 1.54% | 138 561 | 2026-06-30 |
| CSS LLC | 1.23% | 110 422 | 2026-06-30 |
| AZAB MOHAMMAD (Director) | ≈1.16% | 104 925 | 2026-01-09 |
| KLOSK STEVEN MARK (Direc… | ≈1.06% | 95 815 | 2026-01-09 |
| BROWN GREGORY B (Directo… | ≈1.06% | 95 659 | 2026-01-09 |
| FLOWERS CYNTHIA LOUISE (… | ≈1.06% | 95 446 | 2026-01-09 |
| BUCK KRISTEN K (Officer) | ≈1.04% | 93 462 | 2026-01-09 |
| HENSON HEIDI (Director) | ≈0.95% | 85 725 | 2026-01-09 |
| Deltec Asset Management… | 0.92% | 83 197 | 2026-06-30 |
| Rangeley Capital, LLC | 0.9% | 81 000 | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 0.89% | 80 444 | 2026-06-30 |
| Geode Capital Management… | 0.81% | 72 632 | 2026-06-30 |
| Virtu Financial LLC | 0.65% | 58 782 | 2026-06-30 |
| Blackrock Inc. | 0.61% | 54 857 | 2026-06-30 |
| Vanguard Fiduciary Trust… | 0.54% | 48 964 | 2026-06-30 |
| Fidelity Concord Street… | 0.42% | 38 275 | 2026-07-31 |
| IMAM TARIQ (General Coun… | ≈0.4% | 36 078 | 2026-01-09 |
| NISCO JAMES (Officer) | ≈0.36% | 32 311 | 2026-01-09 |
| Fidelity Concord Street… | 0.12% | 10 373 | 2026-07-31 |
| VANGUARD VALLEY FORGE FU… | 0.08% | 7 022 | 2026-06-30 |
| Fidelity Concord Street… | 0.05% | 4 427 | 2026-07-31 |
| Fidelity Concord Street… | 0.05% | 4 379 | 2026-07-31 |
| DFA INVESTMENT DIMENSION… | 0.02% | 2 185 | 2026-07-31 |
| Dimensional ETF Trust-Di… | 0% | 100 | 2026-07-31 |
| Dimensional ETF Trust-Di… | 0% | 8 | 2026-07-31 |
